HDAC9 and cancer: Analysis of cancer-immunity cycle (CIC) features of HDAC pathway CNV revealed a significant difference in immune cycle stages IGS3, IGS4, IGS5, and IGS7 between the two groups in BRCA (p < 0.05) (Figure 5B).